Cargando…

Survey on Recommended Health Care for Adult Patients with Myelodysplastic Syndromes Identifies Areas for Improvement

The impact on health care of patients with myelodysplastic syndromes (MDS) is continuously rising. To investigate the perception of hemato-oncologists concerning the recommended MDS patient care in Switzerland, we conducted a web-based survey on diagnosis, risk-stratification and treatment. 43/309 p...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chanias, Ioannis, Wilk, C. Matthias, Benz, Rudolf, Daskalakis, Michael, Stüssi, Georg, Schmidt, Adrian, Bacher, Ulrike, Bonadies, Nicolas
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7766925/ https://www.ncbi.nlm.nih.gov/pubmed/33371225 http://dx.doi.org/10.3390/ijerph17249562

Ejemplares similares

Myelodysplastic Syndromes in the Postgenomic Era and Future Perspectives for Precision Medicine
por: Chanias, Ioannis, et al.
Publicado: (2021)

Diagnostic and Prognostic Implications of Caspase-1 and PD-L1 Co-Expression Patterns in Myelodysplastic Syndromes
por: Graf, Johannes R., et al.
Publicado: (2021)

Rare Cytogenetic Abnormalities in Myelodysplastic Syndromes
por: Bacher, Ulrike, et al.
Publicado: (2015)

When Should We Think of Myelodysplasia or Bone Marrow Failure in a Thrombocytopenic Patient? A Practical Approach to Diagnosis
por: Bonadies, Nicolas, et al.
Publicado: (2021)

Management of patients with lower-risk myelodysplastic syndromes
por: Brunner, Andrew M., et al.
Publicado: (2022)

Real-world Data From the Swiss Lenalidomide in MDS del(5q) (SLIM)—Registry Identify New Chances and Challenges in Lenalidomide Treatment of Patients With MDS del(5q)
por: Rüfer, Axel, et al.
Publicado: (2022)

Practical recommendations on the use of lenalidomide in the management of myelodysplastic syndromes
por: Giagounidis, Aristoteles, et al.
Publicado: (2008)

Detailed analysis of clonal evolution and cytogenetic evolution patterns in patients with myelodysplastic syndromes (MDS) and related myeloid disorders
por: Schanz, Julie, et al.
Publicado: (2018)

Use of azacitidine for myelodysplastic syndromes: controversial issues and practical recommendations
por: Kim, Yoo-Jin, et al.
Publicado: (2013)

Analysis of the impact of adherence to guidelines and expert advice in patients with myelodysplastic syndromes
por: Kasprzak, A., et al.
Publicado: (2020)

Case Report: Genetic Double Strike: VEXAS and TET2-Positive Myelodysplastic Syndrome in a Patient With Long-Standing Refractory Autoinflammatory Disease
por: Lötscher, Fabian, et al.
Publicado: (2022)

Falls in ED patients: do elderly patients on direct oral anticoagulants bleed less than those on vitamin K antagonists?
por: Müller, Martin, et al.
Publicado: (2021)

Identify latent chromosomal aberrations relevant to myelodysplastic syndromes
por: Song, Qibin, et al.
Publicado: (2017)

The health care setting rather than medical speciality impacts on physicians adherence to guideline-conform anticoagulation in outpatients with non-valvular atrial fibrillation: a cross sectional survey
por: Gerber, Bernhard, et al.
Publicado: (2012)

Potential to Improve Therapy of Chronic Myeloid Leukemia (CML), Especially for Patients with Older Age: Incidence, Mortality, and Survival Rates of Patients with CML in Switzerland from 1995 to 2017
por: Daskalakis, Michael, et al.
Publicado: (2021)

Prognostic Significance of the Myelodysplastic Syndrome-Specific Comorbidity Index (MDS-CI) in Patients with Myelofibrosis: A Retrospective Study
por: Koster, Kira-Lee, et al.
Publicado: (2023)

Machine Learning Improves Risk Stratification in Myelodysplastic Neoplasms: An Analysis of the Spanish Group of Myelodysplastic Syndromes
por: Mosquera Orgueira, Adrian, et al.
Publicado: (2023)

Transfusion Thresholds, Quality of Life, and Current Approaches in Myelodysplastic Syndromes
por: Koutsavlis, Ioannis
Publicado: (2016)

Gene Expression Profiles Identify Biomarkers of Resistance to Decitabine in Myelodysplastic Syndromes
por: Kim, Seungyoun, et al.
Publicado: (2021)

Landscape of genetic lesions in 944 patients with myelodysplastic syndromes
por: Haferlach, T, et al.
Publicado: (2014)

CAR-T Cell Therapy Shows Similar Efficacy and Toxicity in Patients With DLBCL Regardless of CNS Involvement
por: Shumilov, Evgenii, et al.
Publicado: (2023)

Myelodysplastic syndromes
por: Hellström Lindberg, Eva
Publicado: (2018)

BeEAM High-Dose Chemotherapy with Polatuzumab (Pola-BeEAM) before ASCT in Patients with DLBCL—A Pilot Study
por: Stoffel, Tanja, et al.
Publicado: (2022)

Clinical Impact of Single Nucleotide Polymorphism in CD-19 on Treatment Outcome in FMC63-CAR-T Cell Therapy
por: Seipel, Katja, et al.
Publicado: (2023)

Awareness, attitudes, and beliefs about palliative care: Results from a representative survey of the Italian-speaking Swiss population
por: Diviani, Nicola, et al.
Publicado: (2023)

Single-cell RNA sequencing identifies the properties of myelodysplastic syndrome stem cells
por: Liu, Yumei, et al.
Publicado: (2022)

Myelodysplastic Syndrome and Histone Deacetylase Inhibitors: “To Be or Not to Be Acetylated”?
por: Stintzing, Sebastian, et al.
Publicado: (2011)

Multiple Xanthogranulomas in an Adult Patient with Myelodysplastic Syndrome
por: Martínez-García, Marta, et al.
Publicado: (2020)

The incidence of myelodysplastic syndromes in Western Greece is increasing
por: Avgerinou, Christina, et al.
Publicado: (2013)

Angiogenesis in myelodysplastic syndromes
por: Pruneri, G, et al.
Publicado: (1999)

Myelodysplastic Syndromes and Metabolism
por: Balaian, Ekaterina, et al.
Publicado: (2021)

Genetics of Myelodysplastic Syndromes
por: Saygin, Caner, et al.
Publicado: (2021)

Identifying and prioritizing do-not-do recommendations in Dutch primary care
por: van Dulmen, Simone A., et al.
Publicado: (2022)

Genome-wide methylation sequencing identifies progression-related epigenetic drivers in myelodysplastic syndromes
por: Zhou, Jing-dong, et al.
Publicado: (2020)

Myelodysplastic Syndrome and Autoimmunity: A Case Report of an Unusual Presentation of Myelodysplastic Syndrome
por: Merrill, Andrea L., et al.
Publicado: (2011)

Diagnosis of Myelodysplastic Syndromes: From Immunological Observations to Clinical Applications
por: Simoni, Yannick, et al.
Publicado: (2022)

BeEAM Conditioning including High-Dose Bendamustine before Autologous Stem Cell Transplantation Is Safe and Effective in Patients with Waldenstrom’s Macroglobulinemia
por: Heini, Alexander D., et al.
Publicado: (2023)

Inflammasome Activation in Myeloid Malignancies—Friend or Foe?
por: Andina, Nicola, et al.
Publicado: (2022)

Small Area Variation of Adherence to Clinical Recommendations: An Example from Switzerland
por: Gruebner, Oliver, et al.
Publicado: (2022)

Common cardiovascular biomarkers can independently predict outcome of patients with Myelodysplastic syndromes
por: Mitroulis, Ioannis, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_a1m1ge8v767vh1ni0jbkni6r4q